Point prevalence of epilepsy in dementia: A “real‐world” estimate
Antonella Muroni, Gianluca Floris, Giuseppe Borghero, Silvia Ardu, Maria Ida Pateri, Silvy Pilotto, Giada Pisano, Giovanni Defazio- Neurology (clinical)
- Neurology
- General Medicine
Abstract
Objective
Several studies have demonstrated a higher frequency of seizures and epilepsy in Alzheimer's disease and other forms of dementia as compared with healthy elderly individuals. However, incidence and prevalence of epilepsy in the general population of dementia are unknown since most previous studies were performed in secondary‐tertiary referral centres. In addition, all prior studies but one provided “period” rather than “point” prevalence estimates.
Methods
We assessed point prevalence estimate of epileptic manifestations requiring antiepileptic medication in patients Alzheimer's disease, vascular dementia, and fronto‐temporal dementia from a secondary clinical setting.
Results
Point prevalence estimates were 6.4% (95% CI: 1.5 to 11.3) in Alzheimer's disease, 8.9% (95% CI: 1.4 to 16.4), in vascular dementia, and 6% (95% CI: 1.3 to 10.7) in fronto‐temporal dementia, rates that were greater than those observed in the healthy elderly population. Regardless of the etiology of dementia, epilepsy was characterized by unprovoked seizures that lacked distinguishing clinical features.
Significance
These findings support epilepsy as part of the spectrum of dementia. The similar point prevalence of definite epilepsy requiring AED treatment in Alzheimer's disease and non Alzheimer dementias raised the possibility of similar underlying mechanism of epileptogenesis. Although this was not a population‐based study, accurate point prevalence data from clinic setting would be important to better define the burden of epilepsy in dementia and the demands on health services to manage the condition.